2
N.Q. Tuan et al. / Phytochemistry xxx (2016) 1e6
rapid decrease in its population (Korea National Arboretum, 2009).
The leaves of R. brachycarpum have been traditionally used for the
treatment of cardiovascular conditions, hepatitis, hypertension,
rheumatoid arthritis, and headache. Some of these ethno-
pharmacological applications have been validated extensively (Jang
et al., 2005; Popescu and Kopp, 2013). Chemical investigations have
identified various flavonoids, oleanane- and ursane-type triterpe-
noids, and diterpenoids such as the structurally diverse grayano-
toxins as the major constituents (Choi et al., 1986, 1987; Youn and
Cho, 1991).
In ongoing endeavors to discover new chemistry from endan-
gered plant species, identification of the first grayanotox-9(11)-ene
derivative (1) and five known grayanotoxins, grayanoside B (2)
(Sakakibara et al., 1979), rhodomoside A (3) (Bao et al., 2003),
piersformoside (4) (Wang et al., 2000), grayanotoxin III (5)
(Masutani et al., 1979), and grayanotoxin I (6) (Lechtenberg et al.,
2014) from the MeOH extract of R. brachycarpum leaves is
described herein (see Fig. 1).
spectra showed close similarities to those of pieroside C from Pieris
japonica (Ericaceae), a grayanoside carrying grayanotox-9(10)-ene
as its aglycone moiety (Kaiya and Sakakibara, 1985), indicating
the presence of an A-nor-B-homo-ent-kaurene scaffold in 1 (Li
et al., 2013). Structural differences in 1 included a change in the
location and nature of the olefinic moiety and a molecular mass
increase of 16 atomic mass units. The latter implied that compound
1 carried an additional hydroxy group compared to pieroside C. The
HMBC cross-peaks from H-11 and H-20 to C-10, and from H-20 to C-
9 and C-1 located the olefinic and hydroxy moieties as depicted in
Fig. 2, confirming that compound 1 indeed possesses an unprece-
dented grayanotox-9(11)-ene framework. The connectivity of the
aglycone and the monosaccharide unit was established based on
the HMBC cross-peak between H-3 (dH 4.16) and C-10 (dC 106.6). The
7.7 Hz coupling constant of the anomeric proton indicated a
b-
glucosidic linkage and acid hydrolysis followed by LC analysis
verified the presence of a D-(þ)-glucopyranose moiety (Fig. S9).
The relative configuration of 1 was assigned by analysis of the
splitting patterns and coupling constants of diastereotopic protons
and ROESY correlations. The splitting pattern and coupling con-
2. Results and discussion
stants of H-2
moiety comprising the A-ring predominantly adopted a C5-endo
envelope conformation where H-2 and H-3 are eclipsed (Fig. 3A).
The ROESY correlation from H-1 to H3-18 established a trans-fused
A/B-ring junction. The respective - and -orientations of 6-OH and
10-OH were assigned via the ROESY correlations from H-1 to H-6,
and from H-2 to H-20, respectively (Fig. 3B). The ROESY correla-
tion from H-6 to H-14 led to the assignment of the fused mode of
the D-ring with H-13 being -oriented (Fig. 3B). The -orientation
a
(td, J ¼ 13.1, 7.3 Hz) indicated that the cyclopentane
Compound 1 was obtained as a white amorphous powder. Its
molecular formula was established as C26H42O10 based on the
HRESIMS sodium adduct ion at m/z 537.2670 (calcd [MþNa]þ, m/z
537.2676) and 13C NMR data (Table 1). The 1H NMR spectrum
a
b
a
exhibited resonances for one olefinic proton
(dH 5.35), one
b
anomeric proton (dH 5.04), two oxymethine protons (dH 4.14 and
4.17), and two secondary (dH 1.47 and 1.51) and tertiary methyl
group protons (dH 1.41 and 1.96). The 13C NMR spectrum displayed
characteristic resonances for a monosaccharide moiety (dC 106.6,
79.1, 78.9, 76.2, 72.5, and 63.6), two olefinic carbons (dC 117.6 and
156.5), three oxygenated tertiary carbons (dC 86.1, 80.8, and 77.6),
two oxygenated secondary carbons (dC 87.9 and 73.7), two qua-
ternary carbons (dC 51.2 and 46.2), and two tertiary (dC 20.8 and
28.8) and secondary methyl carbons (dC 28.3 and 30.4). Its 1D NMR
a
a
of the C-16 hydroxy group in the D-ring was established via the
ROESY correlation between H2-12 and H3-17 (Fig. 3B).
The assignment of the absolute configuration was attempted by
comparison of the experimental and calculated electronic circular
dichroism (ECD) spectra (Niu et al., 2016). An initial conformational
search was conducted using the MMFF force field in the Macro-
€
Model module (Schrodinger LLC) and the geometry of the identified
conformers were further optimized at the B3LYP/6-31þ(d) level
(Tables S1 and S2). The resulting conformers were subjected to ECD
calculations utilizing the identical theory level and the simulated
ECD spectra were Boltzmann-averaged based on the Gibbs free
energy of each conformer. The comparison of the experimental and
the computed ECD spectra, however, was inconclusive (Fig. 4),
presumably due to the presence of a weak chromophore in 1.
Alternatively, the full 3D structural assignment of 1 was established
employing calculations of shielding tensor values with support
from DP4 plus analysis capable of improving the accuracy of pre-
diction of sp2 carbon shielding tensor values (Grimblat et al., 2015).
Having established the D-glucopyranosyl moiety in 1, di-
astereomers I and II carrying enantiomeric aglycone moieties were
considered (Fig. 5). The major conformers of diastereomers I and II
were found and optimized using the aforementioned approaches
and the GIAO shielding tensors of the generated conformers were
computed at the mPW1PW91/6-31G(d,p) level utilizing the
conductor-like polarizable continuum solvation model (CPCM)
with a dielectric constant representing pyridine (Grimblat et al.,
2015). The calculated shielding tensors were Boltzmann-averaged
based on the corresponding Gibbs free energy of each conformer
and these averaged values were utilized for DP4 plus analysis
(Tables S3eS5). The DP4 plus application demonstrated the struc-
tural equivalence of diastereomer I with compound 1 with 99.95%
probability (Fig. S10). Moreover, stereochemical consistency of the
grayanane architecture originating from the ent-kaurane precursor
further supported the resulting DP4 plus analysis when considered
in conjunction with a similar biosynthesis pathway towards anal-
ogous A-nor-B-homo-diterpenoids (Li et al., 2013).
Table 1
1H (600 MHz) and 13C NMR (150 MHz) spectroscopic data for compound 1 in pyr-
idine-d5.
Position
1
dH, multi. (J in Hz)
dC
1.76, dd (13.9, 6.2)
2.80, td (13.1, 7.3)
50.0
36.0
2
2
3
4
5
6
7
7
8
9
a
b
2.51 (m)
4.17 (m)
e
87.9
51.2
86.1
73.7
45.8
e
4.14, d (11.0)
1.99, d (13.9)
a
b
3.72, dd (13.9, 11.0)
e
46.2
156.5
77.6
117.6
31.7
48.9
44.7
62.3
80.8
28.3
28.8
20.8
30.4
106.6
76.2
79.1
72.5
78.8
63.6
e
10
11
12
13
14
15
16
17
18
19
20
10
e
5.35 (br t)
2.30, d (18.4), 2.21 (m)
2.46 (br t)
2.53 (m), 2.21 (m)
2.59, br d (12.9), 2.22 (m)
e
1.51, s
1.41, s
1.96, s
1.47, s
5.04, d (7.7)
4.09, t (8.2)
4.30, t (8.7)
4.28, t (8.9)
20
30
40
50
4.05, ddd (8.6, 5.4, 2.4)
4.64, dd (11.8, 2.5), 4.44, dd (11.7, 5.5)
60
Please cite this article in press as: Tuan, N.Q., et al., A grayanotox-9(11)-ene derivative from Rhododendron brachycarpum and its structural